TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.

Christian Marth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.